19.01.2018 • NewsadditivesElaine BurridgeHexion

Hexion Sells Additives Technology to Münzing

German specialty additive company Münzing Chemie takes over US resins producer...
German specialty additive company Münzing Chemie takes over US resins producer Hexion's additives technology group (ATG). © Münzing Chemie

US resins producer Hexion (formerly Momentive Specialty Chemicals) has sold its additives technology group (ATG) to German specialty additive company Münzing Chemie for approximately $50 million. The business operated within Hexion’s forest products resins segment.

The sale includes manufacturing sites in Somersby, Australia, and Sungai Petani, Malaysia, along with certain intangible property. The sites produce specialty chemical materials for the engineered wood, paper impregnation and laminating industries, including catalysts, release agents and wetting agents.

 “We are pleased to successfully complete the sale of our ATG business,” said Hexion CEO Craig Rogerson. “We continue to position the company for profitable growth by strategically managing our portfolio and optimizing our cost structure.”

Hexion said it will use the proceeds for general corporate purposes. The Columbus, Ohio-headquartered company is controlled by investment funds affiliated with US private equity group Apollo Global Management.

Privately owned, Münzing has its headquarters in Abstatt and manufacturing plants in Elsteraue and Heilbronn, Germany; Clover, South Carolina, USA; and Taixing, China, which offer broad synthesis and formulation capabilities.

 

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.